Alexandria Petrusich

Alexandria Petrusich has a vast work experience spanning over several companies in the pharmaceutical and biotechnology industry. Alexandria has held various roles in clinical research, development, and operations.

Alexandria's most recent position is as the Vice President of Clinical Science at Prime Medicine, Inc., starting in March 2023.

Prior to joining Prime Medicine, Inc., they worked at bluebird bio from 2022, where they held a role in Clinical Research and Development.

From September 2020 to February 2022, Alexandria served as the Head of Translational Medicine at Graphite Bio.

At bluebird bio, they held multiple positions, including Senior Director of Clinical Science, Clinical Research & Development (2018-2020), Senior Director of Clinical Development Operations (2017-2018), Director of Clinical Development Operations (2015-2017), and Associate Director of Clinical Development Operations (2013-2015).

Before bluebird bio, Alexandria worked as the Director of Clinical Research at Bionovo, Inc. (2011-2013), and as an Associate Director of Clinical Operations at BioMarin Pharmaceutical Inc. (2011).

Alexandria also gained experience as an Associate Director at Eli Lilly and Company (2010-2011), Clinical Program Manager at Sirtris Pharmaceuticals (2007-2010), Clinical Project Manager at Infinity Pharmaceuticals (2006-2007), and Manager of Clinical Operations and Regulatory Affairs at Predix Pharmaceuticals (2003-2006).

Alexandria Petrusich has a Bachelor of Science in Biology from SUNY Geneseo. Alexandria also holds a Certificate in Clinical Research from Boston College's Connell School of Nursing.